Aptose Biosciences Inc. (NASDAQ:APTO) Receives $37.67 Average Price Target from Brokerages

Shares of Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) have been given a consensus recommendation of “Buy” by the six ratings firms that are presently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have covered the […]

Leave a Reply

Your email address will not be published.

Previous post Orioles’ Gunnar Henderson, Adley Rutschman both finish in top 10 of AL MVP voting
Next post Autodesk (NASDAQ:ADSK) Price Target Lowered to $235.00 at Morgan Stanley